These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 3396034)

  • 1. [Lipids and apolipoproteins at the time of onset of type 2 diabetes].
    Válek J; Brunová J; Grafnetter D; Vlasáková Z; Karasová L
    Cas Lek Cesk; 1988 Apr; 127(17):526-30. PubMed ID: 3396034
    [No Abstract]   [Full Text] [Related]  

  • 2. Concentrations of lipids, lipoproteins and apolipoproteins in Zimbabwean diabetic patients.
    Gomo ZA
    East Afr Med J; 1986 Aug; 63(8):550-6. PubMed ID: 3792243
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study on fluctuations of serum lipids in patients with diabetes mellitus. With special reference to effects of control level and therapy].
    Okamoto Y; Nakabayashi H; Nakano H; Fujimori Y; Tsujii T
    Rinsho Byori; 1988 Oct; 36(10):1195-200. PubMed ID: 3246732
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of gemfibrozil on serum lipids, lipoproteins and apolipoproteins in diabetes mellitus with dyslipidemia].
    Liang JZ; Li Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1988 Sep; 19(3):309-11. PubMed ID: 3253180
    [No Abstract]   [Full Text] [Related]  

  • 5. Apolipoproteins in diabetes mellitus.
    Kostner GM; Schernthaner G
    Monogr Atheroscler; 1985; 13():12-24. PubMed ID: 3937046
    [No Abstract]   [Full Text] [Related]  

  • 6. [Analysis of changes in the serum levels of lipids and lipoproteins in obese persons and in patients with diabetes mellitus type 2 associated with obesity].
    Jakubczyk D; Borejszo I; Kinalska I; Szelachowska M; Biedzińska M
    Pol Tyg Lek; 1985 Dec; 40(50):1395-7. PubMed ID: 3831988
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical efficacy of pravastatin for hyperlipidemia in patients with type 2 diabetes mellitus.
    Tawata M; Miwa I; Tsuchiya K; Ozawa M; Shindo H; Wakasugi M; Onaya T
    Arzneimittelforschung; 1995 Jun; 45(6):704-8. PubMed ID: 7646575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of eicosapentaenoic acids on remnant-like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus.
    Nakamura N; Hamazaki T; Kobayashi M; Ohta M; Okuda K
    In Vivo; 1998; 12(3):311-4. PubMed ID: 9706476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of erythrocyte lipid pattern and of some membrane related functions as a consequence of plasma lipid disorder in diabetes mellitus.
    Cignarelli M; Blonda M; Cospite MR; Damato A; Nardelli G; Giorgino R
    Diabete Metab; 1983 Dec; 9(4):272-6. PubMed ID: 6667763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
    Duman BS; Oztürk M; Yilmazer S; Hatemi H
    Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of lipids to coronary heart disease in diabetes mellitus.
    Stewart MW; Laker MF; Alberti KG
    J Intern Med Suppl; 1994; 736():41-6. PubMed ID: 7986307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
    Balogh Z; Seres I; Harangi M; Kovács P; Kakuk G; Paragh G
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):604-10. PubMed ID: 11694861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spectrum of apolipoproteins of blood serum in patients with non- insulin-dependent diabetes mellitus on acarbose treatment].
    Rosliakova LV; Roĭtman AP; Rakov SS; Ametov AS; Dolgov VV
    Klin Med (Mosk); 1999; 77(10):15-7. PubMed ID: 10635646
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
    Chisalita SI; Lindström T; Eson Jennersjö P; Paulsson JF; Westermark GT; Olsson AG; Arnqvist HJ
    Acta Diabetol; 2009 Mar; 46(1):35-42. PubMed ID: 18777156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apolipoproteins are better risk markers than conventional lipids].
    Walldius G; Holme I; Jungner I
    Lakartidningen; 2007 Sep 12-18; 104(37):2612-3. PubMed ID: 17970399
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between plasma fibronectin, serum lipids and apoprotein A and B in healthy male subjects.
    De Giorgio LA; Seghieri G; Niccolai M; Giuntini L; Venturino G; Pettinà G; Innocenti F
    Quad Sclavo Diagn; 1983 Mar; 19(1):73-7. PubMed ID: 6671011
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of a lipid-lowering diet on lipids, lipoproteins and apolipoproteins in the serum].
    Mertz DP; Göhmann E; Ostertag J
    Med Welt; 1982 Sep; 33(38):1302-5. PubMed ID: 7132690
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid and lipoprotein abnormalities in non-insulin dependent diabetics (NIDDM).
    Nitiyanant W; Komoltri C; Ploybutr S; Vannasaeng S; Vichayanrat A; Piraphatdist T
    J Med Assoc Thai; 1987 Mar; 70 Suppl 2():204-8. PubMed ID: 3598433
    [No Abstract]   [Full Text] [Related]  

  • 19. [Environmental factors and serum concentration of lipids and apoproteins A and B in normal subjects].
    Seghieri G; De Giorgio LA; D'Alessandri G; Mammini P; Gironi A; Bartolomei G
    G Clin Med; 1984 Jan; 65(1):33-40. PubMed ID: 6724218
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlation of blood levels of tocopherol, retinol, apolipoproteins and lipids in healthy adult subjects].
    Audisio M; Di Pietro S; Maddalena Peruzzi AM; Maltzeff A; Suraci C
    Boll Soc Ital Biol Sper; 1987 Sep; 63(9):795-802. PubMed ID: 3447620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.